chr3-50402995-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006030.4(CACNA2D2):c.406-8827T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,938 control chromosomes in the GnomAD database, including 8,905 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.29   (  8905   hom.,  cov: 32) 
Consequence
 CACNA2D2
NM_006030.4 intron
NM_006030.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.966  
Publications
7 publications found 
Genes affected
 CACNA2D2  (HGNC:1400):  (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014] 
CACNA2D2 Gene-Disease associations (from GenCC):
- cerebellar atrophy with seizures and variable developmental delayInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.532  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | ENST00000424201.7  | c.406-8827T>C | intron_variant | Intron 3 of 37 | 1 | NM_006030.4 | ENSP00000390329.2 | |||
| CACNA2D2 | ENST00000423994.6  | c.406-8827T>C | intron_variant | Intron 3 of 38 | 5 | ENSP00000407393.2 | ||||
| CACNA2D2 | ENST00000266039.7  | c.406-8827T>C | intron_variant | Intron 3 of 37 | 1 | ENSP00000266039.3 | ||||
| CACNA2D2 | ENST00000360963.7  | c.199-8827T>C | intron_variant | Intron 3 of 37 | 1 | ENSP00000354228.3 | 
Frequencies
GnomAD3 genomes   AF:  0.288  AC: 43797AN: 151818Hom.:  8864  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
43797
AN: 
151818
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.289  AC: 43888AN: 151938Hom.:  8905  Cov.: 32 AF XY:  0.288  AC XY: 21429AN XY: 74296 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
43888
AN: 
151938
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
21429
AN XY: 
74296
show subpopulations 
African (AFR) 
 AF: 
AC: 
22273
AN: 
41392
American (AMR) 
 AF: 
AC: 
5951
AN: 
15260
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
308
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2441
AN: 
5146
South Asian (SAS) 
 AF: 
AC: 
624
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
1648
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
42
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
9956
AN: 
67966
Other (OTH) 
 AF: 
AC: 
508
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1336 
 2672 
 4008 
 5344 
 6680 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 392 
 784 
 1176 
 1568 
 1960 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1012
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.